Establishment of a Parathyroid Tissue Bank
NCT03051126 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10000
Last updated 2020-01-27
Summary
To develop a tissue bank library for patients with parathyroid disease who have undergone surgery and/or biopsy, and/or who may undergo surgical intervention at M. D. Anderson Cancer Center or outside centers, and/or all patients seen through the Parathyroid Center at participating sites, whether or not the patients undergo treatment for their disease. The tissue bank will contain both normal parathyroid tissue and diseased tissue, and will provide a resource for the ongoing study of parathyroid disease and management.
Conditions
- Parathyroid Disease
Interventions
- OTHER
-
Tissue Samples
Fresh residual tissue samples will be obtained during parathyroid and/or pancreas tumor intervention (for pancreas tumor intervention in MEN1 patients with hyperparathyroidism and pancreatic lesions).
Sponsors & Collaborators
-
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Nancy D. Perrier, MD · M.D. Anderson Cancer Center
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-07-09
- Primary Completion
- 2025-07-01
- Completion
- 2025-07-01
Countries
- United States
Study Locations
More Related Trials
-
The Bone-parathyroid Crosstalk in Primary Hyperparathyroidism
NCT05556499 ·Status: NOT_YET_RECRUITING
-
Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid
NCT02274623 ·Status: COMPLETED ·Phase: PHASE1
-
Stem Cell Recruitment in Osteoporosis Therapy
NCT01656629 ·Status: TERMINATED ·Phase: NA
-
The Effects of Therapy With Teriparatide on Vascular Compliance and Osteoprotegerin/RANKL
NCT00347737 ·Status: WITHDRAWN ·Phase: NA
-
One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study
NCT00580788 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Risedronate and Parathyroid Hormone to Reverse Osteoporosis Caused by Chronic Steroid Use
NCT00221299 ·Status: COMPLETED ·Phase: PHASE4
-
Parathyroid Hormone (PTH) for Osteoporosis in Postmenopausal Women
NCT00086619 ·Status: COMPLETED ·Phase: PHASE2
-
Does PTH 1-34 (Teriparatide) Enhance Spinal Fusion in Humans?
NCT02090244 ·Status: COMPLETED ·Phase: PHASE4
-
Denosumab in Primary Hyperparathyroidism
NCT01558115 ·Status: TERMINATED ·Phase: PHASE4
-
Institution of an Italian Multicenter Database of Patients Affected by Hypoparathyroidism or Pseudohypoparathyroidism
NCT06645899 ·Status: RECRUITING
-
3-Week Parathyroid Hormone-related Protein (PTHrP) Dose Escalation Study in Post-Menopausal Women
NCT00222872 ·Status: COMPLETED ·Phase: PHASE1
-
Systematic Treatment After Successful Surgical Treatment for Primary Hyperparathyroidism With Strontium Ranelate
NCT01222026 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of PTH Replacement on Bone in Hypoparathyroidism
NCT00395538 ·Status: TERMINATED ·Phase: PHASE3
-
7 Day Continuous Parathyroid Hormone IV Infusion
NCT00377312 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effect of Vitamin D and Denosumab on Bone Remodelling in Women With Postmenopausal Osteoporosis
NCT05372224 ·Status: COMPLETED ·Phase: NA
-
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
NCT00896454 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Zoledronic Acid in the Prevention of Cancer Therapy-induced Bone Loss
NCT00333229 ·Status: TERMINATED ·Phase: PHASE4
-
Teriparatide (Forteo) in the Treatment of Patients With Postoperative Hypocalcemia
NCT00623974 ·Status: TERMINATED ·Phase: PHASE2
-
OPG/Soluble RANKL (sRANKL) and Bone Mineral Density in Primary Hyperparathyroidism
NCT01889134 ·Status: COMPLETED ·Phase: NA
-
Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer
NCT00049452 ·Status: COMPLETED ·Phase: PHASE3
-
Use of NPSP558 in the Treatment of Hypoparathyroidism
NCT00732615 ·Status: COMPLETED ·Phase: PHASE3
-
One Week Comparison Study of PTH and PTHrP Infusions
NCT01333267 ·Status: WITHDRAWN ·Phase: PHASE1
-
Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients
NCT00824993 ·Status: COMPLETED ·Phase: PHASE3
-
Serum Calcium to Phosphorous Ratio (Ca/P) as a Simple, Inexpensive Screening Tool in the Diagnosis of Primary Hyperparathyroidism
NCT03027349 ·Status: COMPLETED
-
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Osteoporosis
NCT05152381 ·Status: WITHDRAWN ·Phase: PHASE1